Both Akt and JNK have been involved in GBM tumorigenesis, invasiveness, and resistance to antineoplastic agents and radiation and enhanced activity of these protein kinases in response to conventional therapy is reported in established and primary GBM cell lines [48,49,50,51,52,53]. This evidence concerns the gene AKT1 and glioblastoma.